| scholarly article | Q13442814 |
| P2093 | author name string | Pinar Karaca-Mandic | |
| Dana P Goldman | |||
| Geoffrey F Joyce | |||
| P433 | issue | 1 | |
| P921 | main subject | pharmacy | Q614304 |
| P304 | page(s) | 21-28 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | American Journal of Managed Care | Q15807020 |
| P1476 | title | Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy | |
| P478 | volume | 12 |
| Q40168078 | A National Assessment of Medication Adherence to Statins by the Racial Composition of Neighborhoods |
| Q35913842 | A Welfare Measure of "Offset Effects" in Health Insurance |
| Q28540727 | A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development |
| Q37730479 | Alternate Day versus Once Daily Atorvastatin for Primary Prevention of (CHD) in Naïve Patients of Dyslipidemia |
| Q36520468 | An economic analysis of conservative management versus active treatment for men with localized prostate cancer |
| Q37050954 | Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications |
| Q57645944 | Behavioral hazard in health insurance |
| Q21144630 | Can broader diffusion of value-based insurance design increase benefits from US health care without increasing costs? Evidence from a computer simulation model |
| Q33777338 | Can increases in CHIP copayments reduce program expenditures on prescription drugs? |
| Q28686330 | Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts |
| Q37419499 | Cost sharing and the initiation of drug therapy for the chronically ill. |
| Q34248283 | Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis |
| Q37292366 | Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries |
| Q60721925 | Disparities in Statin Use in New York City: Implications for Health Reform |
| Q36085521 | Does medication adherence following a copayment increase differ by disease burden? |
| Q42576240 | Drug licenses: a new model for pharmaceutical pricing |
| Q92548147 | Effects of primary care cost-sharing among young adults: varying impact across income groups and gender |
| Q33931921 | Estimates of commercial population at high risk for cardiovascular events: impact of aggressive cholesterol reduction |
| Q36444054 | Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population |
| Q34556420 | Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. |
| Q35752951 | How patient cost-sharing trends affect adherence and outcomes: a literature review. |
| Q37365655 | Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. |
| Q93085588 | Integrated Insurance Design in the Presence of Multiple Medical Technologies |
| Q39455827 | Medication Nonadherence: The Role of Cost, Community, and Individual Factors |
| Q34509195 | Nonlinear pricing in drug benefits and medication use: the case of statin compliance in Medicare Part D. |
| Q37125842 | Out-of-pocket medication costs and use of medications and health care services among children with asthma |
| Q33932365 | Partial compliance with antipsychotics increases mental health hospitalizations in schizophrenic patients: analysis of a national managed care database |
| Q34313865 | Patient Cost-Sharing and Hospitalization Offsets in the Elderly |
| Q36869615 | Prescription drug cost sharing: associations with medication and medical utilization and spending and health. |
| Q36596889 | Rationale for multiple risk intervention: the need to move from theory to practice. |
| Q33630092 | Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data |
| Q89915582 | Small Ideas for Saving Big Health Care Dollars |
| Q33412577 | Systematic review on quality control for drug management programs: is quality reported in the literature? |
| Q37310249 | The Impact of Health Insurance Policy Changes on Californians with Severe Chronic Disease |
| Q35828712 | The Impact of the US Food and Drug Administration Chlorofluorocarbon Ban on Out-of-pocket Costs and Use of Albuterol Inhalers Among Individuals With Asthma |
| Q37837744 | The potential impact of comparative effectiveness research on U.S. health care expenditures. |
| Q57822900 | Trends in Antineoplastic Receipt after Medicare Payment Reform: Implications for Future Oncology Payment Design |
| Q36085479 | Value-based insurance design: more health at any price |
| Q36699426 | What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries |
Search more.